Kurt Kruger

Kurt Kruger

Director/Board Member presso QUALIGEN THERAPEUTICS, INC.

Patrimonio netto: 720 $ in data 31/03/2024

68 anni
Health Technology
Consumer Services
Finance

Profilo

Kurt H.
Kruger
is the founder of Kleb LLC, which was founded in 2023.
He is currently a Director at Qualigen, Inc., an Independent Director at Qualigen Therapeutics, Inc., and a Partner & Healthcare at WR Hambrecht + Co. LLC.
Mr. Kruger's former positions include Marketing Manager at Guidant Corp.
from 1984 to 1987, Analyst at Banc of America Securities LLC in 2003, Chief Financial Officer at Cyberkinetics Neurotechnology Systems, Inc. from 2006 to 2008, and Chief Financial Officer at EMI Holding, Inc. from 2018 to 2019.
Mr. Kruger's education history includes an undergraduate degree from Brown University, a graduate degree from the University of Michigan, and a graduate degree from MIT Sloan School of Management.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
25/03/2024 1 800 ( 0.03% ) 720 $ 31/03/2024

Posizioni attive di Kurt Kruger

SocietàPosizioneInizio
QUALIGEN THERAPEUTICS, INC. Director/Board Member 01/01/2020
Analyst-Equity 01/06/2014
Director/Board Member -
Tutte le posizioni attive di Kurt Kruger

Precedenti posizioni note di Kurt Kruger

SocietàPosizioneFine
Director of Finance/CFO 03/06/2019
Director of Finance/CFO 14/03/2008
Analyst-Equity 25/02/2003
Sales & Marketing 01/07/1987
Vedi nel dettaglio l'esperienza di Kurt Kruger

Formazione di Kurt Kruger

Brown University Undergraduate Degree
University of Michigan Graduate Degree
MIT Sloan School of Management Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kurt Kruger

Relazioni

26

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private7

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Finance

Qualigen Therapeutics, Inc.

Vedi le connessioni aziendali